| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5597357 | The Annals of Thoracic Surgery | 2017 | 7 Pages |
Abstract
LDE-PACLI promoted strong improvement of cardiac allograft vasculopathy, but the decrease in coronary stenosis by LDE-MTX and LDE-MTX/PACLI was not significant. All three treatments decreased macrophage infiltration in the graft. These results may encourage future clinical trials to test this new therapeutic approach to coronary allograft vasculopathy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Lucas R. MD, Domingos D. MD, PhD, Elaine R. PhD, Priscila O. PhD, Paulo S. MD, PhD, Raul C. MD, PhD, Noedir A.G. MD, PhD,